The state of Alabama currently has 1 active clinical trials seeking participants for Hepatitis C research studies. These trials are conducted in various cities, including Birmingham, Mobile, Huntsville and Anniston.
Rapid HCV Treatment Access for Persons Who Use Drugs
Recruiting
This study is being done to compare two strategies to deliver HCV treatment to persons with hepatitis C virus (HCV) who also use drugs and are participating in an outpatient opioid treatment program (OTP). Participants will be randomized into one of two treatment groups: Test and treat plus peer-mentors: This treatment group will be offered 8 weeks of glecaprevir/pibrentasvir (an FDA approved HCV treatment) within days of HCV diagnosis at the OTP. Participants in this group will receive treatme... Read More
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
11/08/2023
Locations: University of Alabama, Birmingham, Alabama
Conditions: Hepatitis C Virus Infection, Response to Therapy of